OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.
Peleg
Anton Y
AY
Franklin
Clare
C
Walters
Luke J
LJ
Bell
Jan M
JM
Spelman
Denis W
DW
D000150:Acinetobacter / Q000187:drug effects* / Q000201:enzymology* / Q000302:isolation & purification; D000151:Acinetobacter Infections / Q000097:blood / Q000382:microbiology; D001315:Australia; D015780:Carbapenems / Q000378:metabolism* / Q000494:pharmacology; D004269:DNA, Bacterial / Q000032:analysis; D024881:Drug Resistance, Bacterial / Q000502:physiology*; D006801:Humans; D006868:Hydrolysis; D007093:Imidazoles / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010880:Piperidines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000378:metabolism*
D015780:Carbapenems; D004269:DNA, Bacterial; D007093:Imidazoles; D010880:Piperidines; D065093:beta-Lactamase Inhibitors; C085755:4-(1H-imidazol-4-ylmethyl)piperidine; C425142:beta-lactamase IMP-4; D001618:beta-Lactamases; C509061:beta-lactamase OXA-58, Acinetobacter junii